We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
Dentsply Sirona
XRAY
$1.87B
| $1.3M | ﹤0.01% |
29,549
+16,088
| +120% | +$680K |
|
|
HMHC
1152
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.3M | ﹤0.01% |
717,037
+714,529
| +28,490% | +$1.15M |
|
1153
Cabot Corp
CBT
$4B
| $1.3M | ﹤0.01% |
35,007
-8,193
| -19% | -$274K |
|
1154
Devon Energy
DVN
$53.6B
| $1.29M | ﹤0.01% |
114,193
-24,307
| -18% | -$277K |
|
1155
Arcus Biosciences
RCUS
$3.25B
| $1.29M | ﹤0.01% |
52,225
-45,182
| -46% | -$1.22M |
|
|
CLDR
1156
DELISTED
Cloudera, Inc.
CLDR
| $1.29M | ﹤0.01% |
+101,590
| New | +$976K |
|
1157
Agree Realty
ADC
$8.48B
| $1.29M | ﹤0.01% |
+19,602
| New | +$1.25M |
|
|
NPKI
1158
NPK International
NPKI
$1.08B
| $1.29M | ﹤0.01% |
576,926
+26,748
| +5% | +$45.3K |
|
1159
Saia
SAIA
$9.09B
| $1.29M | ﹤0.01% |
11,564
-6,891
| -37% | -$660K |
|
1160
Bruker
BRKR
$9.61B
| $1.28M | ﹤0.01% |
31,554
-90,644
| -74% | -$3.57M |
|
|
DNKN
1161
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $1.28M | ﹤0.01% |
19,665
-80,610
| -80% | -$5.02M |
|
1162
ITT
ITT
$18.1B
| $1.28M | ﹤0.01% |
21,810
-153
| -0.7% | -$8.11K |
|
1163
CNX Resources
CNX
$4.96B
| $1.28M | ﹤0.01% |
147,541
-18,131
| -11% | -$182K |
|
1164
Five Below
FIVE
$13B
| $1.27M | ﹤0.01% |
11,913
-312
| -3% | -$29.3K |
|
1165
Acco Brands
ACCO
$402M
| $1.27M | ﹤0.01% |
179,210
-180,266
| -50% | -$1.12M |
|
|
XEC
1166
DELISTED
CIMAREX ENERGY CO
XEC
| $1.27M | ﹤0.01% |
46,183
+19,689
| +74% | +$488K |
|
|
SCTL
1167
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.27M | ﹤0.01% |
278,404
-137,857
| -33% | -$853K |
|
1168
Dycom Industries
DY
$8.61B
| $1.25M | ﹤0.01% |
30,686
+15,027
| +96% | +$519K |
|
1169
Douglas Emmett
DEI
$1.72B
| $1.25M | ﹤0.01% |
40,816
-627
| -2% | -$18.8K |
|
|
CDK
1170
DELISTED
CDK Global, Inc.
CDK
| $1.24M | ﹤0.01% |
29,943
-2,350
| -7% | -$90.4K |
|
1171
Curtiss-Wright
CW
$21B
| $1.24M | ﹤0.01% |
13,864
-333
| -2% | -$31.7K |
|
1172
Cencora
COR
$59B
| $1.24M | ﹤0.01% |
12,280
-91,245
| -88% | -$8.4M |
|
|
TECD
1173
DELISTED
Tech Data Corp
TECD
| $1.23M | ﹤0.01% |
8,490
-442
| -5% | -$61.1K |
|
|
PDLI
1174
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.23M | ﹤0.01% |
422,069
-15,888
| -4% | -$50.2K |
|
1175
Badger Meter
BMI
$3.7B
| $1.23M | ﹤0.01% |
+19,485
| New | +$1.16M |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.